The role of mesenchymal stem cells in peripheral blood in patients with pulmonary hypertension.

The role of mesenchymal stem cells in peripheral blood in patients with pulmonary hypertension. - The role of mesenchymal stem cells in peripheral blood in patients with pulmonary hypertension.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032832

Enrollment

Registered

2018-06-01

Start date

2016-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with pulmonary hypertension 2.Patients who have a history of hospitalization for evaluation of pulmonary hypertension 3.Patients who can continue to receive treatment of pulmonary hypertension in outpatient clinic 4.Patients who agreed to participate in this study

Exclusion criteria

Exclusion criteria: 1.Patients with active infectious diseases and inflammatory diseases 2.Patients with fatal acute diseases such as acute coronary syndrome or acute pulmonary embolism 3.Patients with blood disorders 4.Pregnant women and patients who may become pregnant in the future 5.Patients with cancer and under chemotherapy and/or radiotherapy 6.Patients who the doctor considers inappropriate as subject of this study

Design outcomes

Primary

Measure	Time frame
The relationship between severity of pulmonary hypertension and the frequency of mesenchymal stem cells in peripheral blood.	—

Secondary

Measure	Time frame
The relationship between the frequency of mesenchymal stem cells in peripheral blood and prognosis of pulmonary hypertension.	—

Countries

Japan

Contacts

Public ContactMiyake Yasuko

Kanazawa University Innovative Clinical Research Center

crc.irb-knz@esct.jp076-265-2048

Outcome results